Literature DB >> 22441742

The minimal important difference for residual volume in patients with severe emphysema.

Jorine E Hartman1, Nick H T Ten Hacken, Karin Klooster, H Marike Boezen, Mathieu H G de Greef, Dirk-Jan Slebos.   

Abstract

Residual volume (RV) measured by body plethysmography is a routine measurement in clinical pulmonary practice and is often an important outcome variable in clinical trials. However, it is not known what size of improvement can be regarded as being important in severe emphysema patients. Therefore, the aim of the study is to establish the minimal important difference (MID) for RV in severe emphysema patients undergoing bronchoscopic lung volume reduction. 91 severe emphysema patients were included. RV and total lung capacity (TLC) were measured by body plethysmography. MID estimates were calculated by anchor-based and distribution-based methods. Forced expiratory volume in 1 s, 6-min walk distance and St George's Respiratory Questionnaire total score were used as anchors and Cohen's effect size was used as distribution-based method. The calculated MID estimates according to the different anchors and methods ranged between -0.31 and -0.43 L for RV, -6.1 and -8.6% for percentage change in RV (RV%) from baseline, and -2.8 and -4.0% for RV/TLC. These MID estimates are useful for sample size determination in new studies on interventions aimed at reducing RV and for interpreting the results from clinical trials in severe emphysema patients.

Entities:  

Mesh:

Year:  2012        PMID: 22441742     DOI: 10.1183/09031936.00219111

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

1.  First in Human Experience of the Performance of the New 5.5-LP Size Zephyr Endobronchial Valve.

Authors:  Karin Klooster; Marlies van Dijk; T David Koster; Dirk-Jan Slebos
Journal:  Respiration       Date:  2019-11-26       Impact factor: 3.580

2.  One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial.

Authors:  Karin Klooster; Jorine E Hartman; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2016-12-15       Impact factor: 3.580

3.  Significant Differences in Body Plethysmography Measurements Between Hospitals in Patients Referred for Bronchoscopic Lung Volume Reduction.

Authors:  Jorrit B A Welling; Jorine E Hartman; Nick H T Ten Hacken; Sonja W S Augustijn; Huib A M Kerstjens; Dirk-Jan Slebos; Karin Klooster
Journal:  Lung       Date:  2019-08-31       Impact factor: 2.584

Review 4.  Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease.

Authors:  Joseph Em van Agteren; Khin Hnin; Dion Grosser; Kristin V Carson; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

5.  Use of Ventilation-Perfusion Single-Photon Emission Computed Tomography to Select the Target Lobe for Endobronchial Valve Lung Volume Reduction.

Authors:  Vanessa Sze Theen Tee; Phan Nguyen; Hubertus Jersmann; Dion Grosser; Benjamin Crouch; Brett Lorraine; Chong Ghee Chew
Journal:  Respiration       Date:  2021-03-26       Impact factor: 3.580

6.  Protocol of a Randomized Controlled Study of the PneumRx Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema (ELEVATE).

Authors:  Felix J F Herth; Dirk-Jan Slebos; Pallav L Shah; Martin Hetzel; Gerald Schmid-Bindert; Adam S LaPrad; Gaëtan Deslée; Arschang Valipour
Journal:  Respiration       Date:  2019-11-19       Impact factor: 3.580

7.  Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO.

Authors:  Marlies van Dijk; Jorine E Hartman; Karin Klooster; Nick H T Ten Hacken; Huib A M Kerstjens; Dirk-Jan Slebos
Journal:  Respiration       Date:  2020-01-21       Impact factor: 3.580

8.  Endobronchial coil therapy in severe emphysema: 6-month outcomes from a Swiss National Registry.

Authors:  Jean-Marc Fellrath; Thomas Scherer; Daniel P Franzen; Alban Lovis; Christophe von Garnier; Jérôme Plojoux; Paola M Soccal
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

9.  Identifying Responders and Exploring Mechanisms of Action of the Endobronchial Coil Treatment for Emphysema.

Authors:  Jorine E Hartman; Karin Klooster; Sonja W S Augustijn; Wouter H van Geffen; Justin L Garner; Pallav L Shah; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2021-03-19       Impact factor: 3.580

10.  Effects of endobronchial coils for endoscopic lung volume reduction on sleep in COPD patients with advanced pulmonary emphysema.

Authors:  Karl-Josef Franke; Ulrike Domanski; Maik Schröder; Georg Nilius
Journal:  Sleep Breath       Date:  2020-08-26       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.